Combined assays on isolated heart mitochondria and Cor.4U hiPS-derived cardiomyocytes to predict drug-induced cardiotoxicity

2018 ◽  
Vol 295 ◽  
pp. S200-S201
Author(s):  
C. Martel ◽  
C. Pertuiset ◽  
B. Aubry ◽  
M. Porceddu ◽  
N. Buron ◽  
...  
Drug Research ◽  
2020 ◽  
Vol 70 (04) ◽  
pp. 151-157 ◽  
Author(s):  
Enayatollah Seydi ◽  
Yasaman Tabbati ◽  
Jalal Pourahmad

AbstractPropranolol and atenolol are known as β receptor blocker drugs. These drugs are used to treat some heart diseases. There are controversies in the relationship between the use of beta-blocker drugs and the level of reactive oxygen species (ROS). Mitochondria as one of the most important sources of ROS are considered as one of the targets of drug-induced cardiotoxicity. The aim of this study was to evaluate the effects of propranolol and atenolol on mitochondria isolated from the heart. To achieve this aim, several markers of mitochondrial and cellular toxicity were evaluated. The key results of this study are the increased ROS level, collapse in mitochondrial membrane potential (MMP), mitochondrial swelling and cytochrome c release as well as disruption of respiratory chain complex II in mitochondria in isolated heart mitochondria after exposure to propranolol and atenolol. The results indicate an increase in caspase-3 activity and a decrease in the ATP level in cardiomyocytes after exposure to propranolol and atenolol. The underlying mechanisms of propranolol and atenolol induced cardiotoxicity may be associated with alterations in mitochondrial function, oxidative stress, and changes in the mitochondrial membrane.


1992 ◽  
Vol 30 (4) ◽  
pp. 347-358 ◽  
Author(s):  
Werner Offermann ◽  
Evi Fiedler ◽  
Corinna Helmle-Kolb ◽  
Werner Hofer ◽  
Harald Kugel ◽  
...  

Aging Cell ◽  
2007 ◽  
Vol 6 (5) ◽  
pp. 607-618 ◽  
Author(s):  
Adrian J. Lambert ◽  
Helen M. Boysen ◽  
Julie A. Buckingham ◽  
Ting Yang ◽  
Andrej Podlutsky ◽  
...  

BIOPHYSICS ◽  
2007 ◽  
Vol 52 (6) ◽  
pp. 582-586 ◽  
Author(s):  
I. V. Sviryaeva ◽  
E. K. Ruuge ◽  
K. B. Shumaev

1971 ◽  
Vol 43 (1) ◽  
pp. 50-57 ◽  
Author(s):  
G.P. Brierley ◽  
M. Jurkowitz ◽  
K.M. Scott ◽  
K.M. Hwang ◽  
A.J. Merola

1989 ◽  
Vol 178 (2) ◽  
pp. 348-354 ◽  
Author(s):  
Dennis W. Jung ◽  
Michael H. Davis ◽  
Gerald P. Brierley

2013 ◽  
Vol 68 (1) ◽  
pp. e29 ◽  
Author(s):  
Brandon Borders ◽  
Brian Roche ◽  
John Ross ◽  
Tom Vinci ◽  
Brandon Wood ◽  
...  

1984 ◽  
Vol 217 (1) ◽  
pp. 117-121 ◽  
Author(s):  
A L Kerbey ◽  
I D Caterson ◽  
P F Williams ◽  
J R Turtle

The proportion of active, dephosphorylated, pyruvate dehydrogenase complex was decreased in the mouse heart by obesity (by 56%), and this decrease in enzyme activity persisted during preparation and extraction of heart mitochondria. Phosphorylation and inactivation of pyruvate dehydrogenase may be a major factor in mediating the inhibitory effects of obesity on glucose oxidation in muscle, and this may represent an important mechanism in the development and/or expression of cellular insulin-resistance.


Sign in / Sign up

Export Citation Format

Share Document